Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kündig Group is a long-established Swiss raw produce and food ingredients company centered on W. Kündig & Cie, with operations in trading, processing, and sterilization of agricultural and botanical raw materials. The group is not a traditional drug developer, but it does have a healthcare-adjacent business through its BIOSTERIL unit, which provides GMP-compliant germ-reduction and sterilization services for phytopharmaceutical raw materials, traditional Chinese medicine inputs, and more recently medical cannabis flower. Its core technology is a vacuum-steam-vacuum decontamination process operated from Ritschenhausen, Germany, where it processes dried botanicals and other sensitive materials at commercial scale. Recent company communications indicate expansion of this service into the European medical cannabis market, including sterilization, packaging, and co-packing capabilities. Overall, Kündig Group should be viewed primarily as a food/raw-materials processor with a specialized pharma-service capability rather than as a biotech or pharmaceutical innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KunDing Group.